Constance Susan Houck, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 17 | 2021 | 3474 | 1.500 |
Why?
|
| Societies, Medical | 6 | 2021 | 3740 | 1.000 |
Why?
|
| Anesthesia | 7 | 2019 | 1562 | 0.990 |
Why?
|
| Hate | 1 | 2024 | 10 | 0.970 |
Why?
|
| Surgical Procedures, Operative | 7 | 2020 | 1877 | 0.920 |
Why?
|
| Organizational Policy | 4 | 2021 | 428 | 0.890 |
Why?
|
| Urologic Surgical Procedures | 6 | 2019 | 301 | 0.890 |
Why?
|
| Laparoscopy | 9 | 2019 | 2148 | 0.820 |
Why?
|
| Anesthetics, Local | 6 | 2019 | 985 | 0.820 |
Why?
|
| Anesthetics | 2 | 2019 | 539 | 0.810 |
Why?
|
| Anesthesiology | 5 | 2020 | 1060 | 0.730 |
Why?
|
| Bupivacaine | 3 | 2019 | 411 | 0.710 |
Why?
|
| Water-Electrolyte Balance | 1 | 2020 | 346 | 0.650 |
Why?
|
| Body Temperature Regulation | 1 | 2020 | 252 | 0.640 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2018 | 230 | 0.560 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2019 | 290 | 0.550 |
Why?
|
| Hospitals, Pediatric | 4 | 2023 | 1775 | 0.550 |
Why?
|
| Airway Management | 1 | 2020 | 329 | 0.550 |
Why?
|
| Morphine | 2 | 2019 | 657 | 0.540 |
Why?
|
| Quality Improvement | 4 | 2020 | 3750 | 0.530 |
Why?
|
| Hyperkalemia | 1 | 2017 | 218 | 0.520 |
Why?
|
| Pain, Postoperative | 5 | 2019 | 1642 | 0.480 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 582 | 0.480 |
Why?
|
| Urologic Diseases | 1 | 2016 | 243 | 0.460 |
Why?
|
| Analgesics, Opioid | 6 | 2019 | 3677 | 0.450 |
Why?
|
| United States Food and Drug Administration | 2 | 2019 | 1582 | 0.420 |
Why?
|
| Child | 40 | 2024 | 77637 | 0.420 |
Why?
|
| Pain | 8 | 2023 | 4987 | 0.400 |
Why?
|
| Nephrectomy | 1 | 2017 | 1048 | 0.400 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 805 | 0.390 |
Why?
|
| Specialties, Surgical | 3 | 2020 | 391 | 0.380 |
Why?
|
| Resuscitation Orders | 3 | 2018 | 269 | 0.360 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1503 | 0.360 |
Why?
|
| Developing Countries | 1 | 2022 | 2815 | 0.360 |
Why?
|
| Inpatients | 1 | 2021 | 2515 | 0.360 |
Why?
|
| Robotics | 6 | 2013 | 899 | 0.350 |
Why?
|
| Anesthesia, General | 1 | 2017 | 1171 | 0.350 |
Why?
|
| Pain Measurement | 6 | 2019 | 3420 | 0.320 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 1452 | 0.320 |
Why?
|
| Codeine | 1 | 2016 | 49 | 0.290 |
Why?
|
| Intubation, Intratracheal | 3 | 2010 | 1365 | 0.290 |
Why?
|
| Drug Therapy | 1 | 2020 | 496 | 0.280 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2211 | 0.280 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2016 | 366 | 0.240 |
Why?
|
| Conscious Sedation | 4 | 2013 | 527 | 0.230 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 259 | 0.230 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 710 | 0.220 |
Why?
|
| Anesthesia, Local | 1 | 2005 | 275 | 0.220 |
Why?
|
| Emergencies | 1 | 2020 | 1170 | 0.220 |
Why?
|
| Brain | 2 | 2022 | 26345 | 0.220 |
Why?
|
| Models, Biological | 1 | 2019 | 9582 | 0.220 |
Why?
|
| Endothelin-1 | 1 | 2004 | 314 | 0.220 |
Why?
|
| Anesthesia, Caudal | 1 | 2002 | 25 | 0.210 |
Why?
|
| Analgesia | 3 | 2023 | 461 | 0.210 |
Why?
|
| Humans | 59 | 2024 | 743811 | 0.200 |
Why?
|
| Neurons, Afferent | 1 | 2004 | 504 | 0.200 |
Why?
|
| Advisory Committees | 2 | 2018 | 775 | 0.200 |
Why?
|
| Medical Staff Privileges | 1 | 2020 | 14 | 0.190 |
Why?
|
| Infant | 17 | 2023 | 35122 | 0.190 |
Why?
|
| Health Resources | 2 | 2020 | 912 | 0.190 |
Why?
|
| History, 20th Century | 2 | 2020 | 2736 | 0.190 |
Why?
|
| Infant, Newborn | 10 | 2020 | 25609 | 0.190 |
Why?
|
| Physicians | 1 | 2019 | 4569 | 0.180 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 546 | 0.180 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2019 | 139 | 0.180 |
Why?
|
| General Surgery | 3 | 2019 | 1636 | 0.180 |
Why?
|
| Referral and Consultation | 2 | 2014 | 3530 | 0.180 |
Why?
|
| Anesthesia, Epidural | 1 | 2002 | 228 | 0.180 |
Why?
|
| Tolmetin | 2 | 1996 | 23 | 0.180 |
Why?
|
| Air Ambulances | 1 | 2000 | 90 | 0.170 |
Why?
|
| Transportation of Patients | 1 | 2000 | 185 | 0.170 |
Why?
|
| Premedication | 1 | 2010 | 258 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2021 | 294 | 0.170 |
Why?
|
| Perioperative Care | 2 | 2017 | 1002 | 0.160 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 632 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 5 | 2023 | 1161 | 0.160 |
Why?
|
| Kidney Pelvis | 2 | 2011 | 188 | 0.160 |
Why?
|
| Specialty Boards | 1 | 2020 | 227 | 0.160 |
Why?
|
| United States | 12 | 2023 | 69859 | 0.160 |
Why?
|
| Regional Medical Programs | 1 | 2018 | 71 | 0.160 |
Why?
|
| Sucrose | 2 | 2016 | 164 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 7270 | 0.160 |
Why?
|
| Thoracic Vertebrae | 1 | 2002 | 608 | 0.150 |
Why?
|
| Organizational Innovation | 1 | 2020 | 559 | 0.150 |
Why?
|
| Aerosols | 1 | 2019 | 623 | 0.140 |
Why?
|
| Certification | 1 | 2020 | 423 | 0.140 |
Why?
|
| Social Justice | 1 | 2021 | 457 | 0.140 |
Why?
|
| Organizational Culture | 1 | 2020 | 510 | 0.140 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2016 | 40 | 0.140 |
Why?
|
| Anesthesia Recovery Period | 1 | 2017 | 157 | 0.140 |
Why?
|
| Insufflation | 1 | 2016 | 65 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2019 | 767 | 0.130 |
Why?
|
| Medication Errors | 1 | 2021 | 798 | 0.130 |
Why?
|
| Anesthetics, General | 1 | 2017 | 152 | 0.130 |
Why?
|
| Surgicenters | 1 | 2015 | 46 | 0.130 |
Why?
|
| Penis | 1 | 2016 | 214 | 0.130 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 788 | 0.130 |
Why?
|
| Drug Administration Schedule | 2 | 2021 | 4931 | 0.130 |
Why?
|
| Costs and Cost Analysis | 2 | 2018 | 1680 | 0.120 |
Why?
|
| Acetaminophen | 2 | 2016 | 545 | 0.120 |
Why?
|
| Anxiety | 2 | 2012 | 4288 | 0.120 |
Why?
|
| Infant Care | 1 | 2016 | 179 | 0.120 |
Why?
|
| Child, Preschool | 14 | 2019 | 40964 | 0.120 |
Why?
|
| Age Factors | 4 | 2019 | 18355 | 0.120 |
Why?
|
| Administration, Topical | 1 | 2016 | 689 | 0.120 |
Why?
|
| Touch | 1 | 2016 | 304 | 0.120 |
Why?
|
| Emergency Medical Services | 3 | 2020 | 1917 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2016 | 324 | 0.110 |
Why?
|
| Sweetening Agents | 1 | 2016 | 295 | 0.110 |
Why?
|
| Analgesics | 2 | 2010 | 1040 | 0.100 |
Why?
|
| Airway Obstruction | 1 | 1997 | 662 | 0.100 |
Why?
|
| Canada | 1 | 2017 | 2064 | 0.100 |
Why?
|
| Obstetrics | 1 | 2019 | 657 | 0.100 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 1209 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2017 | 1532 | 0.090 |
Why?
|
| Critical Illness | 1 | 2023 | 2670 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 2281 | 0.090 |
Why?
|
| Body Size | 1 | 2013 | 461 | 0.090 |
Why?
|
| Respiration | 1 | 1997 | 1653 | 0.090 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 2568 | 0.090 |
Why?
|
| Replantation | 1 | 2011 | 148 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2000 | 2265 | 0.090 |
Why?
|
| Nerve Block | 1 | 2016 | 644 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2453 | 0.090 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 957 | 0.090 |
Why?
|
| Photic Stimulation | 1 | 2016 | 2019 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2013 | 2064 | 0.080 |
Why?
|
| Ureteral Obstruction | 1 | 2011 | 296 | 0.080 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2011 | 427 | 0.080 |
Why?
|
| Emergency Service, Hospital | 3 | 2020 | 7658 | 0.080 |
Why?
|
| Ureter | 1 | 2011 | 375 | 0.080 |
Why?
|
| Ketorolac | 2 | 2000 | 79 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1403 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.080 |
Why?
|
| Parents | 3 | 2021 | 3403 | 0.080 |
Why?
|
| Breast Feeding | 1 | 2016 | 1338 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 840 | 0.070 |
Why?
|
| Cicatrix | 1 | 2012 | 763 | 0.070 |
Why?
|
| Antitussive Agents | 1 | 2016 | 17 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2016 | 106 | 0.070 |
Why?
|
| Electrophoresis | 1 | 2005 | 240 | 0.070 |
Why?
|
| Skin Absorption | 1 | 2005 | 94 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2019 | 63042 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3608 | 0.060 |
Why?
|
| Communication | 1 | 2019 | 3748 | 0.060 |
Why?
|
| Adolescent | 10 | 2021 | 85729 | 0.060 |
Why?
|
| Glucose | 1 | 2016 | 4398 | 0.060 |
Why?
|
| Male | 15 | 2019 | 349776 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 674 | 0.050 |
Why?
|
| Dosage Forms | 1 | 2021 | 56 | 0.050 |
Why?
|
| Drug Storage | 1 | 2021 | 51 | 0.050 |
Why?
|
| Pamphlets | 1 | 2021 | 75 | 0.050 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 607 | 0.050 |
Why?
|
| Ureterostomy | 1 | 2000 | 17 | 0.050 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 116 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2004 | 3839 | 0.050 |
Why?
|
| Cystostomy | 1 | 2000 | 26 | 0.050 |
Why?
|
| 4-Butyrolactone | 1 | 2000 | 63 | 0.050 |
Why?
|
| Spasm | 1 | 2000 | 121 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3503 | 0.040 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 151 | 0.040 |
Why?
|
| Female | 14 | 2019 | 380020 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 2002 | 427 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2000 | 166 | 0.040 |
Why?
|
| Muscle Relaxants, Central | 1 | 2010 | 86 | 0.040 |
Why?
|
| Solvents | 1 | 2000 | 302 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2019 | 53250 | 0.040 |
Why?
|
| Prodrugs | 1 | 2000 | 263 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2021 | 398 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 1997 | 47 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2013 | 4687 | 0.040 |
Why?
|
| Pregnancy | 1 | 2019 | 29140 | 0.040 |
Why?
|
| Latex | 1 | 1996 | 52 | 0.040 |
Why?
|
| Medication Systems | 1 | 1996 | 31 | 0.040 |
Why?
|
| Capnography | 1 | 1997 | 89 | 0.040 |
Why?
|
| Hydromorphone | 1 | 1996 | 65 | 0.040 |
Why?
|
| Syringes | 1 | 1996 | 56 | 0.030 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1996 | 109 | 0.030 |
Why?
|
| Health Literacy | 1 | 2021 | 414 | 0.030 |
Why?
|
| Tromethamine | 1 | 1995 | 31 | 0.030 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1996 | 133 | 0.030 |
Why?
|
| Bleeding Time | 1 | 1995 | 89 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 1997 | 395 | 0.030 |
Why?
|
| Prilocaine | 1 | 2004 | 19 | 0.030 |
Why?
|
| Tetracaine | 1 | 2004 | 35 | 0.030 |
Why?
|
| Anesthetics, Combined | 1 | 2004 | 40 | 0.030 |
Why?
|
| Young Adult | 3 | 2017 | 56392 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2000 | 1459 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2000 | 6356 | 0.030 |
Why?
|
| Information Systems | 1 | 1996 | 410 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 1422 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 1997 | 371 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8300 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 4584 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 1996 | 669 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 1996 | 409 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2013 | 77410 | 0.030 |
Why?
|
| Language | 1 | 2021 | 1468 | 0.030 |
Why?
|
| Postoperative Complications | 4 | 2013 | 15281 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 1995 | 255 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2000 | 1199 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10940 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 12944 | 0.030 |
Why?
|
| Informed Consent | 1 | 2018 | 995 | 0.020 |
Why?
|
| Lidocaine | 1 | 2004 | 544 | 0.020 |
Why?
|
| Safety | 1 | 1996 | 1184 | 0.020 |
Why?
|
| Esthetics | 1 | 2012 | 305 | 0.020 |
Why?
|
| Epinephrine | 1 | 2004 | 792 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1997 | 1351 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2016 | 6535 | 0.020 |
Why?
|
| Radiography | 1 | 2002 | 7010 | 0.020 |
Why?
|
| Cost Savings | 1 | 1996 | 925 | 0.020 |
Why?
|
| Laparotomy | 1 | 2012 | 473 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2004 | 599 | 0.020 |
Why?
|
| Resuscitation | 1 | 2004 | 658 | 0.020 |
Why?
|
| Caregivers | 1 | 2021 | 2098 | 0.020 |
Why?
|
| Animals | 2 | 2016 | 168660 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 795 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1996 | 1131 | 0.020 |
Why?
|
| Length of Stay | 2 | 2013 | 6311 | 0.020 |
Why?
|
| Drug Costs | 1 | 1996 | 1105 | 0.020 |
Why?
|
| Internet | 1 | 2000 | 3058 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1997 | 1558 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2018 | 1470 | 0.020 |
Why?
|
| Rats | 1 | 2004 | 24250 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 1996 | 884 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4245 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 1996 | 1102 | 0.020 |
Why?
|
| Peritoneum | 1 | 2008 | 227 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 1653 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2883 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2004 | 3912 | 0.020 |
Why?
|
| Acute Disease | 1 | 1997 | 7150 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2001 | 6061 | 0.020 |
Why?
|
| Program Development | 1 | 2013 | 1314 | 0.020 |
Why?
|
| Perception | 1 | 2012 | 1198 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2013 | 1210 | 0.020 |
Why?
|
| Logistic Models | 1 | 2000 | 13404 | 0.020 |
Why?
|
| Patient Preference | 1 | 2012 | 889 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19894 | 0.020 |
Why?
|
| Data Collection | 1 | 2004 | 3339 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2004 | 1205 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1996 | 2146 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3953 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2013 | 2483 | 0.010 |
Why?
|
| Decision Making | 1 | 2018 | 3887 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5078 | 0.010 |
Why?
|
| Chloral Hydrate | 1 | 2001 | 28 | 0.010 |
Why?
|
| Wound Healing | 1 | 2012 | 2776 | 0.010 |
Why?
|
| Recurrence | 1 | 1993 | 8337 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 3391 | 0.010 |
Why?
|
| Curriculum | 1 | 2013 | 3603 | 0.010 |
Why?
|
| Double-Blind Method | 3 | 2000 | 12020 | 0.010 |
Why?
|
| Incidence | 1 | 1996 | 20948 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1993 | 9139 | 0.010 |
Why?
|
| Meperidine | 1 | 1997 | 38 | 0.010 |
Why?
|
| Promethazine | 1 | 1997 | 29 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1997 | 111 | 0.010 |
Why?
|
| Therapeutic Equivalency | 1 | 1996 | 141 | 0.010 |
Why?
|
| Midazolam | 1 | 1997 | 270 | 0.010 |
Why?
|
| Ketorolac Tromethamine | 1 | 1995 | 21 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1997 | 480 | 0.010 |
Why?
|
| Narcotics | 1 | 1997 | 343 | 0.010 |
Why?
|
| Hemostasis, Surgical | 1 | 1995 | 128 | 0.010 |
Why?
|
| Fentanyl | 1 | 1997 | 409 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40038 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 21733 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 1150 | 0.010 |
Why?
|
| Death | 1 | 1997 | 678 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 1958 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 25032 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1996 | 2029 | 0.010 |
Why?
|
| Inflammation | 1 | 1996 | 10629 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 35409 | 0.000 |
Why?
|